source
- Caldera Therapeutics completes reverse merger with Synlogic, secures $278 million financingCaldera Therapeutics, a Massachusetts biotech founded last year, announced a reverse merger with Nasdaq-listed Synlogic, giving it a public listing. The transaction includes a $278 million financi…
- Teva says it has time to prepare for upcoming US tariffs on imported generic drugsTeva CEO Richard Francis said the company believes it has sufficient time to prepare for the tariffs the Trump administration is considering on generic drugs imported from outside the United States…